+ Site Statistics
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Leucocyte migration agarose test to study cell-mediated immunity in amoebiasis

Leucocyte migration agarose test to study cell-mediated immunity in amoebiasis

Southeast Asian Journal of Tropical Medicine and Public Health 12(3): 346-352

The leucocyte migration agarose test (LMAT) was used to measure quantitatively the magnitude of cell-mediated immunity (CMI) in 35 patients with amoebic liver abscess and 22 healthy controls. LMAT was positive in 65.7% and 85.7% of patients with amoebiasis in the presence of 200 microgram and 400 microgram of the amoeba extract respectively, whereas the test in all 22 healthy controls was negative. Time course studies showed that within 10 days after the onset of clinical illness, only 1 of 4 patients was positive. Thereafter the percentage positivity was raised, especially when 400 microgram antigen was used. Maximum CMI response was apparent between 31-60 days after the onset of clinical illness. The indirect haemagglutination (IHA) test showed that all patients and 5 of 22 healthy controls were positive. These was no correlation between IHA titers and the magnitude of LMAT reaction.

(PDF 0-2 workdays service: $29.90)

Accession: 000921567

Download citation: RISBibTeXText

PMID: 7342321

Related references

Application of the leucocyte adherence inhibition test to the assessment of cell mediated immunity in invasive amoebiasis. Transactions of the Royal Society of Tropical Medicine and Hygiene7(1): 121-125, 1983

Cell-mediated immunity in uveitis. 1. Leucocyte migration inhibition test. Nippon Ganka Gakkai Zasshi 78(6): 301-305, 1974

Examination of cell-mediated immunity using the leukocyte migration inhibition test in agarose. Zeitschrift für die Gesamte Innere Medizin und Ihre Grenzgebiete 32(4): 54-55, 1977

Effect of phytohaemagglutinin in the leucocyte migration inhibition test as a measure of cell-mediated immunity. Journal of Clinical Pathology 27(2): 113-117, 1974

Cell mediated immunity in brain tumour patients - an in vitro analysis using a leucocyte migration inhibition test. Medical Science Research 24(12): 825-827, 1996

Cell-mediated immunity: correlation of mixed-leucocyte-macrophage migration inhibition with delayed-type hypersensitivity after immunization and donor-specific transfer of cell migration inhibition by dialyzable leucocyte extract. Cellular Immunology 82(1): 147-162, 1983

In vitro evaluation of cell-mediated immunity in mice: experiments with soluble and cellular antigens in a spleen-thymus cell leucocyte migration test (LMT). Clinical and Experimental Immunology 8(2): 163-171, 1971

Comparison between the direct capillary tube leucocyte migration technique (LMCT) and the direct agarose leucocyte migration technique (LMAT) as indicators of tumour-directed cell-mediated hypersensitivity (TCMH) in patients with renal carcinoma. Acta Allergologica 31(2): 141-158, 1976

Studies on cell-mediated immunity in patients with colorectal cancer: leucocyte migration inhibition test using allogenic 3M KCl extract. Australian and New Zealand Journal of Surgery 51(5): 434-439, 1981

Leucocyte migration inhibitory activity (LMIA) on concanavalin A (Con-A) stimulated human lymphocytes. Comparison of leucocyte migration capillary technique (LMCT), leucocyte migration agarose technique (LMAT), and leucocyte migration fibrinolysis technique (LMFT). Acta Pathologica et Microbiologica Scandinavica. Section C, Immunology 84c(6): 485-488, 1976

LEUCOCYTE MIGRATION INHIBITORS CTIVITY (LMIA) ON CONCANAVALIN (CON-A) STIMULATED HUMAN LYMPHOCYTES : Comparison of Leucocyte Migration Capillary Technique (LMCT), Leucocyte Migration Agarose Technique (LMAT), and Leucocyte Migration Fibrinolysis Technique (LMFT). Apmis 84c(6): 485-488, 1976

Cell-mediated immunity to hepatitis-associated antigen (HAA) demonstrated by leucocyte migration test during and after acute B hepatitis. Biomedicine / 19(9): 379-383, 1973

Technical study of the leucocyte migration inhibition test in agarose. Application to PPD and to hepatitis B antigen. Clinical and Experimental Immunology 18(3): 439-448, 1974

Agarose microdroplet leucocyte migration technique for detection of cell-mediated hypersensitivity to PPD and renal carcinoma antigen. Clinical and Experimental Immunology 30(1): 168-172, 1977

Leucocyte migration and cell-mediated immunity in syphilis. British Journal of Venereal Diseases 48(6): 483-488, 1972